<DOC>
	<DOCNO>NCT00853983</DOCNO>
	<brief_summary>The aim study show body absorbs , metabolise excretes drug [ 14C ] AZD0530 . As clinical trial , safety tolerability drug evaluate .</brief_summary>
	<brief_title>Phase I Study Assess Absorption , Metabolism &amp; Excretion Single Oral Dose 14CAZD0530 Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Saracatinib</mesh_term>
	<criteria>Regular Daily Bowel movement Veins suitable cannulation repeat venepuncture Presence clinically significant illness Abnormal vital sign History presence gastrointestinal , hepatic renal disease condition know interfere absorption , distribution , metabolism excretion drug</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Healthy Volunteers</keyword>
	<keyword>ADME</keyword>
</DOC>